-
2023/12/21
Megakaryon Corporation has become a consolidated subsidiary of Sysmex Corporation.
Notice of Management change -
2023/10/26
Notice of Management change -
2022/10/27
Notice of Management change -
2022/06/02
Megakaryon Corporation initiates first-in-human clinical trial of allogenic human iPSC-derived HLA homozygous platelets (MEG-002). -
2021/10/27
Notice of Management change -
2021/04/26
Megakaryon Corporation announces the completion of 30-day review of Clinical trial notification submitted for human iPS cell-derived HLA homozygous platelets (MEG-002). -
2020/10/27
Notice of Management change -
2020/06/22
Contract for manufacturing of clinical trial formulations -
2020/02/17
Megakaryon Raises Yen 2.8 Billion in Series D Financing -
2020/02/14
Megakaryon Corporation along with the partner companies won the Minister of State for Science and Technology Policy Award at the 2nd Japan Open Innovation contest.
